drugset / Trial / NCT00781404
Myocardial Protection With Adenosine During Primary Percutaneous Coronary Intervention in Pts With STEMI
Phase 3
Completed
201 enrolled
David Garcia-Dorado
Hospital Clínico Universitario de Valladolid · collabHospital General Universitario Gregorio Marañon · collabHospital Universitario Virgen Macarena · collabInstituto de Ciencias del Corazon · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
OBJECTIVE: to evaluate the safety and efficacy of a brief intracoronary infusion of ADO applied at the time of reperfusion to limit infarct size and LV remodelling in patients with ACSST submitted to primary ACTP. DESIGN: Multicentric, prospective, randomised, parallel, placebo-controlled double-blind study. PATIENTS: 200 patients older than 18 with ACSST and without prior myocardial infarction receiving primary PTCA within 6 hours after symptom onset.
Timeline
- Start
- 2008-10
- Primary completion
- 2012-05
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adenosine | Small molecule | 4 mg | Other |